Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,320 | 1,899 | -2,660 | -9,021 | -9,933 |
| Depreciation Amortization | 666 | 446 | 242 | 1,901 | 1,618 |
| Accounts receivable | -1,643 | -1,232 | -1,022 | 3,619 | 3,973 |
| Accounts payable and accrued liabilities | -52 | 537 | -530 | -8 | -720 |
| Other Working Capital | 2,005 | 1,514 | -2 | 7,661 | 6,964 |
| Other Operating Activity | 4,132 | 2,391 | 2,424 | 669 | 79 |
| Operating Cash Flow | $6,428 | $5,555 | $-1,548 | $4,821 | $1,981 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -38 | -26 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -2,750 | -2,750 |
| Other Investing Activity | 0 | 0 | 0 | -2,750 | -2,750 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-2,788 | $-2,776 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -770 | -385 | N/A | -385 | -385 |
| Common Stock Issued | 288 | 272 | 132 | 251 | 152 |
| Other Financing Activity | -181 | -181 | -181 | 0 | 0 |
| Financing Cash Flow | $-663 | $-294 | $-49 | $-134 | $-233 |
| Beginning Cash Position | 16,305 | 16,305 | 16,305 | 14,406 | 14,406 |
| End Cash Position | 22,070 | 21,566 | 14,708 | 16,305 | 13,378 |
| Net Cash Flow | $5,765 | $5,261 | $-1,597 | $1,899 | $-1,028 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,428 | 5,555 | -1,548 | 4,821 | 1,981 |
| Capital Expenditure | N/A | N/A | N/A | -38 | -26 |
| Free Cash Flow | 6,428 | 5,555 | -1,548 | 4,783 | 1,955 |